Bertha C. Ekeh
Research Subjects
Bertha C. Ekeh has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
Abiodun H. Bello
University of Ilorin Teaching Hospital Ilorin Nigeria
1 shared publicationAbiodun J. Kehinde
Federal Medical Center, Jabi, Federal Capital Territory Abuja Nigeria
1 shared publicationAkintunde A. Adebowale
Neurology Unit, Department of Medicine Obafemi Awolowo University/Obafemi Awolowo University Teaching Hospitals Complex Ile‐Ife Nigeria
1 shared publication- Anaelechi J. Onuegbu
Department of Chemical Pathology, Faculty of Basic Clinical Sciences, Nnamdi Azikiwe University, Nnewi, Nigeria
1 shared publication - Augustine Chinedu Ihim
Department of Medical Laboratory Science, Faculty of Health Sciences and Technology, Nnamdi Azikiwe University, Awka Anambra, Nigeria
1 shared publication Babatunde A. Ademiluyi
Federal Medical Center Lokoja Nigeria
1 shared publication
Latest Publications
- Open Access
- 14 September 2023
- Published by Sciencedomain International in Asian Journal of Medicine and Health
- Vol. 21 (11) , 27-35
Evaluation of Thyroid Function of HIV Patients in Umunze, Anambra State, Nigeria
- 14 September 2023
- Published by Sciencedomain International in Asian Journal of Medicine and Health
- Vol. 21 (11) , 27-35
Open AccessEvaluation of Thyroid Function of HIV Patients in Umunze, Anambra State, Nigeria
- 16 September 2021
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 8 (8) , 1206-1215
A Cross‐Sectional Comprehensive Assessment of the Profile and Burden of Non‐motor Symptoms in Relation to Motor Phenotype in the Nigeria Parkinson Disease Registry Cohort
Background: Data on non‐motor symptoms (NMS) in black Africans with Parkinson's disease (PD) are sparse.Objective: To describe the profile of NMS in the Nigeria PD Registry (NPDR) cohort and explore the relationship between NMS and PD motor phenotype.Methods: We conducted a cross‐sectional study of the frequency and burden of NMS, based on the non‐motor symptoms scale (NMSS) and the Chaudhuri method respectively in our cohort. Baseline demographics, disease characteristics (Hoehn and Yahr stage, MDS‐UPDRS total score and Part III motor score), motor phenotype (based on Stebbin et al's algorithm), and levodopa equivalent daily dose (LEDD) were documented.Results: Data are presented for 825 PD whose mean age at study was 63.7 ± 10.1 years, female sex—221 [26.8%] while median PD duration was 36 months. PD phenotypes included tremor‐dominant 466 (56.5%), postural instability and gait disorder (PIGD) 259 (31.4%), and indeterminate 100 (12.1%). 82.6% were on treatment (median LEDD of 500 mg/24 hours). 804 (97.5%) endorsed at least 1 NMS. The median NMSS score was 26.0 while subscores for urinary and sexual function domains were significantly higher in males (P < 0.05). PIGD‐PD had more frequent NMS and higher frequency of severe/very severe NMSS burden (P = 0.000 for both). Nocturia and fatigue were the most prevalent NMS overall and across motor subtypes. PIGD phenotype and total UPDRS scores were the independent determinants of NMSS scores (P = 0.000).Conclusion: The profile and burden of NMS, and association with motor subtype in our black African cohort is largely similar to descriptions from other populations.
- 16 September 2021
- Published by Wiley in Movement Disorders Clinical Practice
- Vol. 8 (8) , 1206-1215
A Cross‐Sectional Comprehensive Assessment of the Profile and Burden of Non‐motor Symptoms in Relation to Motor Phenotype in the Nigeria Parkinson Disease Registry Cohort
Background: Data on non‐motor symptoms (NMS) in black Africans with Parkinson's disease (PD) are sparse.Objective: To describe the profile of NMS in the Nigeria PD Registry (NPDR) cohort and explore the relationship between NMS and PD motor phenotype.Methods: We conducted a cross‐sectional study of the frequency and burden of NMS, based on the non‐motor symptoms scale (NMSS) and the Chaudhuri method respectively in our cohort. Baseline demographics, disease characteristics (Hoehn and Yahr stage, MDS‐UPDRS total score and Part III motor score), motor phenotype (based on Stebbin et al's algorithm), and levodopa equivalent daily dose (LEDD) were documented.Results: Data are presented for 825 PD whose mean age at study was 63.7 ± 10.1 years, female sex—221 [26.8%] while median PD duration was 36 months. PD phenotypes included tremor‐dominant 466 (56.5%), postural instability and gait disorder (PIGD) 259 (31.4%), and indeterminate 100 (12.1%). 82.6% were on treatment (median LEDD of 500 mg/24 hours). 804 (97.5%) endorsed at least 1 NMS. The median NMSS score was 26.0 while subscores for urinary and sexual function domains were significantly higher in males (P < 0.05). PIGD‐PD had more frequent NMS and higher frequency of severe/very severe NMSS burden (P = 0.000 for both). Nocturia and fatigue were the most prevalent NMS overall and across motor subtypes. PIGD phenotype and total UPDRS scores were the independent determinants of NMSS scores (P = 0.000).Conclusion: The profile and burden of NMS, and association with motor subtype in our black African cohort is largely similar to descriptions from other populations.